Search by Drug Name or NDC
NDC 55154-0132-05 Lidocaine Hydrochloride and Epinephrine 10; 10 ug/mL; mg/mL Details
Lidocaine Hydrochloride and Epinephrine 10; 10 ug/mL; mg/mL
Lidocaine Hydrochloride and Epinephrine is a INFILTRATION INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cardinal Health 107, LLC. The primary component is EPINEPHRINE; LIDOCAINE HYDROCHLORIDE.
Product Information
NDC | 55154-0132 |
---|---|
Product ID | 55154-0132_db20c49e-fd0c-4ae8-af26-fe0d6b4983aa |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Lidocaine Hydrochloride and Epinephrine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | lidocaine hydrochloride anhydrous and epinephrine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INFILTRATION |
Active Ingredient Strength | 10; 10 |
Active Ingredient Units | ug/mL; mg/mL |
Substance Name | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
Labeler Name | Cardinal Health 107, LLC |
Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA089644 |
Listing Certified Through | 2024-12-31 |
Package
NDC 55154-0132-05 (55154013205)
NDC Package Code | 55154-0132-5 |
---|---|
Billing NDC | 55154013205 |
Package | 5 VIAL, MULTI-DOSE in 1 BAG (55154-0132-5) / 20 mL in 1 VIAL, MULTI-DOSE |
Marketing Start Date | 2010-04-05 |
NDC Exclude Flag | N |
Pricing Information | N/A |